What are the main immune-disordered diseases? — Ipex
The manifestations associated with What are the main diseases? These issues raise important clinical questions and require specialized guidance to avoid the risks of self-medication or unnecessary restrictions. When addressing the topic "What are the main immune-disordered diseases? — Ipex"This educational guide brings together the practical knowledge of the medical team from the Brazil Without Allergies Project in order to clarify the triggering factors, the most accurate diagnostic tests, and the modern therapeutic strategies currently available.
✔ Medical content reviewed and validated by the founding clinical staff of the Brazil Without Allergies Project
Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.
Clinical Analysis and Medical Guidance on the Main Diseases
To the immune dysregulation diseases (Category IV of the classification of Inborn Errors of Immunity) International Union of Immunological Societies Immunodysregulatory syndromes (IUSs) represent one of the greatest diagnostic challenges in internal medicine, pediatrics, and clinical immunology. Because they present with multisystemic signs and symptoms that mimic severe allergic dermatoses, inflammatory enteropathies, rheumatological diseases, and hematological malignancies, they require a high index of clinical suspicion and targeted molecular investigation. The pathophysiology, diagnostic criteria, and evidence-based management of the main immunodysregulatory syndromes are detailed below.
1. IPEX Syndrome and IPEX-like Phenotypes (FOXP3 Mutation)
The syndrome IPEX (X-linked Immunodysregulation, Polyendocrinopathy, and Enteropathy) results from mutations in the gene FOXP3, encoder of the master transcription factor indispensable for the development and suppressor function of regulatory T lymphocytes (Treg, CD4+CD25+FOXP3+)The functional loss of Treg cells promotes an intense immunological shift towards inflammatory profiles. Th2 and Th17, accelerated apoptosis with accumulation of cellular debris and premature loss of self-tolerance.
- Classic clinical triad: (1) severe eczematous dermatitis of neonatal or infant onset (phenotypically similar to severe atopic dermatitis); (2) severe autoimmune/eosinophilic enteropathy with intractable diarrhea; and (3) autoimmune endocrinopathy early onset (especially neonatal type 1 diabetes mellitus and autoimmune thyroiditis).
- Laboratory findings and diagnosis: sharp rise of Total IgE and peripheral eosinophiliaFrequent positivity for autoantibodies anti-GAD (glutamic acid decarboxylase) and anti-enterocyte (which may be confused with celiac disease); IgG, IgA, and IgM levels are generally preserved, except when there is severe enteric protein loss. The numerical count of CD4 lymphocytes+CD25+FOXP3+ In cytometry, it can be normal in mutations. missensemaking the genetic sequencing The gold standard. Cases with identical phenotype and gene. FOXP3 normal syndromes are configured IPEX-like (including deficiencies in CD25, CTLA-4, LRBA and STAT1/STAT3 gain of function).
- Therapeutic approach: bridging immunosuppression with Sirolimus (mTOR inhibitor that selectively preserves residual Treg cells), being the hematopoietic stem cell transplantation (HSCT) the definitive curative treatment.
2. CTLA-4 Deficiency (CTLA-4 Haploinsufficiency)
Inheritance condition autosomal dominant resulting from a defect in the main inhibitory brake on lymphocyte co-stimulation. At the immunological synapse between the antigen-presenting cell (via MHC) and the T lymphocyte, the binding of CD80/CD86 to the receiver CD28 It accelerates immune activation, while the protein CTLA-4 CTLA-4 competes for CD80/CD86 to curb this response. In CTLA-4 deficiency, the loss of this "brake pad" triggers lymphocyte hyperactivation with a predominance of autoimmune manifestations (autoimmune hemolytic anemia, immune thrombocytopenia, arthritis, and enteropathy) associated with respiratory infections caused by encapsulated germs.
- Laboratory profile and management: Hypogammaglobulinemia (reduction of IgG, IgA, and IgM) with a drop in CD19 B lymphocytes.+, maintaining T subpopulations (CD3+, CD4+, CD8+) and NK cells (CD56+) usually in normal absolute numbers. Confirmation requires genetic sequencing. Treatment employs abatacept (CTLA-4-Ig), Sirolimusmonoclonal antibody anti-CD20 (rituximab) for the control of B-cell mediated manifestations and, in severe refractory cases, hematopoietic stem cell transplantation (HSCT).
3. LRBA deficiency
Inborn error of inheritance autosomal recessive in which there is an absence of the intracellular protein LRBACTLA-4 is responsible for preventing lysosomal degradation of CTLA-4 and promoting its recycling to the cell surface. Although the CTLA-4 gene is intact, its functional expression in the membrane is severely depleted. Clinically, it resembles CTLA-4 deficiency, differing in its higher frequency and earlier onset. sinopulmonary infections caused by encapsulated bacteria combined with autoimmune cytopenias and lymphoproliferation. Pharmacological management is based on abatacept, Sirolimus, anti-CD20, immunoglobulin replacement and HSCT.
4. STAT1 Protein Defects (Loss of Function vs. Gain of Function)
In the interferon signaling pathway (IFN type I and type II), the activation of tyrosine kinases JAK promotes phosphorylation of the transcription factor STAT1, which translocates to the cell nucleus to modulate pro-inflammatory genes and the Th1/Th17 response:
- Loss-of-function mutations (loss-of-function — LOF, autosomal recessive): They cause severe susceptibility to mycobacterial and viral infections, resembling severe combined immunodeficiencies.
- Gain-of-function mutations (gain-of-function — GOF, autosomal dominant): They promote hyperactivation of the JAK/STAT1 pathway, leading to chronic mucocutaneous candidiasis, autoimmune diseases (endocrinopathies, cytopenias), lymphoproliferation, reduced NK cells, and variable hypogammaglobulinemia. Management utilizes selective JAK inhibitors (such as ruxolitinib or baricitinib), Sirolimus and evaluation for TCTH.
5. STAT3 Functional Deficiency / Gain
Intracellular mediator of signaling interleukin-6 (IL-6)the protein STAT3 regulates the balance between Th17 differentiation and FOXP3 expression in regulatory T cells. Gain-of-function mutations in STAT3 (heritage autosomal dominant(with a 50% probability of transmission to offspring) present with autoimmune cytopenias, autoimmune enteropathy, lymphocytic interstitial lung disease, and early type 1 diabetes mellitus (autoantibodies against pancreatic beta cells, distinct from type 2 diabetes due to insulin resistance). Laboratory tests show a reduction in total IgG, normal IgM, and CD4 lymphopenia.+ and reduction of NK cells, with increased cellular expression of STAT3/SOCS3 in functional research assays and confirmation by genetic sequencing. The treatment includes mycophenolate mofetil, tacrolimus, azathioprine, anti-IL-6 receptor monoclonal antibody (tocilizumab), JAK/STAT inhibitors, anti-CD20 and TCTH.
6. Activated PI3K-Delta Syndrome (APDS — PI3K Pathway Hyperactivation)
Inheritance autosomal dominant, results from mutations in genes PIK3CD or PIK3R1 which involve phosphatidylinositol (PIP2/PIP3) signaling and SH2 regulatory domains, generating constitutive hyperactivation of the pathway PI3K-delta/AKT/mTOR in interleukin and lymphocyte antigen receptors. Clinically, it is characterized by recurrent respiratory infections, Persistent or severe viremia caused by viruses of the Herpesviridae family (especially EBV and CMV) and high risk of EBV-induced lymphomaThe management includes sirolimus/tacrolimus, anti-CD20, selective PI3K-delta inhibitors (such as leniolisib and nemiralisib) and TCTH.
7. Autoimmune Lymphoproliferative Syndrome (ALPS and ALPS-like Phenotypes)
It results from genetic defects in the pathway of FAS receptor-mediated lymphocyte apoptosis (usually autosomal dominant, or rarely autosomal recessive), preventing physiological programmed cell death after the immune response and generating peripheral accumulation of autoreactive lymphocytes.
- Clinical and laboratory findings: Non-infectious chronic lymphadenopathy, splenomegaly, lupus-like conditions and autoimmune cytopenias (Coombs-positive hemolytic anemia and immune thrombocytopenia). Classic laboratory findings include pathognomonic elevation of double-negative T cells (CD3)+TCRαβ+CD4−CD8−)IgG hypergammaglobulinemia frequently associated with Isolated selective IgA deficiency and autoantibody positivity. Diagnosis requires genetic confirmation and differentiation from syndromes. ALPS-likeTreatment involves administering pulsed corticosteroids during flare-ups. Sirolimus (highly effective in reducing double-negative cells) anti-CD20 and, in selected refractory cases, TCTH.
8. Macrophage Activation Syndrome (MAS) and Hemophagocytic Lymphohistiocytosis (HLH)
A potentially fatal hyperinflammatory condition of the innate and cytotoxic immune system, characterized by a massive storm of pro-inflammatory cytokines. It can be primary/genetic—associated with syndromic immunodeficiencies with a defect in the exocytosis of cytotoxic granules, such as... Chediak-Higashi syndromea Griscelli syndrome and the X-linked lymphoproliferative syndrome (XLP) — or secondary to viral infections (such as EBV), neoplasms, and autoimmune/autoinflammatory diseases.
- Clinical and laboratory diagnostic criteria: persistent high fever, hepatosplenomegaly, cytopenias affecting two or more hematopoietic lineages (hemoglobin < 9.0 g/dL [90 g/L], platelets < 100,000/mm³3, neutropenia), hypertriglyceridemia (> 2.0 mmol/L) and/or hypofibrinogenemia (< 1.5 g/L), marked hyperferritemia, elevation of the soluble IL-2 receptor (sCD25), reduction or absence of cytotoxic activity of NK cells and histopathological demonstration of hemophagocytosis in aspirated/biopsy of bone marrow or lymph node (strictly avoiding splenic biopsy due to the high risk of rupture and severe hemorrhage).
- Emergency medical procedures: early institution of targeted immunosuppression with dexamethasone combined with cyclosporine (and specific protocols for HLH/SAM), followed by definitive treatment of the underlying disease.
💎 Diamond Plan — Complex immunological diseases require specialized and continuous monitoring. Speak with an Allergy and Immunology specialist via teleconsultation, from anywhere in Brazil. Schedule a teleconsultation →
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Immunology of the Digestive Mucosa: Gut-Airway Axis and Differential Diagnosis
Epithelial Barrier, Eosinophilic Inflammation, and Intestinal Permeability
The balance between commensal microbiota and the digestive mucosa directly regulates systemic immunological tolerance. Proteins such as gliadin can modulate zonulin release in genetically susceptible individuals (carriers of HLA-DQ2 or HLA-DQ8 alleles in celiac disease), increasing intestinal permeability and perpetuating local and extraintestinal inflammatory cascades. Careful distinction between celiac autoimmunity, IgE-mediated wheat allergy, and FODMAP carbohydrate fermentation avoids inappropriate management.
Multidisciplinary Approach between Allergology and Gastroenterology
Diagnostic confirmation relies on the correlation between specific serological tests, digestive endoscopy with serial biopsies, and... allergy test focused on food and inhalant allergens that coexist in atopic patients. Therefore, establishing strategies to... vaccine for food allergy Integrated with allergy control, it allows for the restoration of the digestive mucosa, the control of associated symptoms, and the safe preservation of nutritional status.
Epithelial Dysfunction, Skin Microbiome, and Delayed Sensitization
The skin acts as the first organ of immune defense in the human body. In atopic dermatitis, genetic alterations in structural proteins of the stratum corneum (such as filaggrin) and in the composition of ceramides cause transepidermal water loss, pronounced dryness, and facilitated entry of mites and aeroallergens. This microenvironment activates Th2 cytokines (especially IL-4, IL-13, and IL-31, directly linked to intense itching) and favors colonization by Staphylococcus aureus, whose superantigens perpetuate eczematous flare-ups.
Th1/Th17 Inflammatory Axis, Environmental Triggers, and Epidermal Barrier
At the interface between Clinical Immunology, Dermatology, and Rheumatology, a systemic patient assessment allows for the early recognition of metabolic and joint comorbidities, as well as any coexisting hypersensitivities. Tests such as the Antinuclear Antibody (ANA) and inflammatory markers act as screening tools that only acquire real diagnostic significance when interpreted in light of a detailed physical examination of the skin, nails, scalp, and joints.
Vaccine Mechanisms, Excipients, and Assessment of Immune Competence
Preventive immunization represents one of the greatest achievements of medicine in reducing hospitalizations and serious infectious complications, especially in patients with chronic respiratory diseases (such as asthma and COPD), heart disease, high blood pressure, and diabetes. Patients allergic to aeroallergens, foods, or common medications do not have a general contraindication to vaccines; allergological attention focuses on the specific evaluation of rare cases of previous anaphylaxis to isolated components of the formula (such as polyethylene glycol, polysorbate, or specific protein traces), situations that now have safe assisted application protocols.
Selective Blockade of Cytokines (IL-4, IL-5, IL-13, TSLP) and Immunoglobulin E
Choosing the ideal immunobiological agent requires rigorous phenotyping and endotyping by a specialist physician, evaluating blood biomarkers (peripheral eosinophil count, serum levels of total IgE and exhaled fraction of nitric oxide) and coexisting comorbidities, such as severe asthma, nasal polyposis, refractory chronic spontaneous urticaria, and moderate to severe atopic dermatitis. Subcutaneous applications follow a regular schedule under safe clinical supervision.
Environmental Prevention, Therapeutic Adherence, and Continuous Monitoring
Long-term success in managing allergic and immunological conditions depends directly on the alliance between targeted medical treatment and daily educational measures. Maintaining well-ventilated environments free from accumulated household dust, preserving the physiological hydration of mucous membranes and the skin barrier, strictly adhering to the schedules and technique for using prescribed preventive medications, and conducting periodic check-ups allow for the stabilization of subclinical inflammation before it progresses to acute exacerbations.
Clinical Safety Criteria and Warning Signs in Allergology
Early recognition of warning signs requiring priority medical reassessment is part of the health education of every patient and their family. Symptoms such as progressive dyspnea (difficulty breathing or speaking in complete sentences), refractory wheezing, sudden edema of the lips, tongue, or glottis, dizziness due to a drop in blood pressure, persistent fever associated with skin lesions or mucous membrane involvement require immediate emergency care, followed by a structured allergy investigation to prevent future recurrences.
Impact on Quality of Life, Sleep, and Systemic Well-being
Beyond direct physical manifestations, uncontrolled conditions linked to what are the main diseases profoundly interfere with restorative sleep architecture, concentration capacity at school and work, and emotional balance. Chronic stress, through neuroendocrine mediators and epithelial alarmins, feeds back into the immune inflammatory response. Therefore, instituting a comprehensive approach to clinical and environmental rehabilitation restores daily autonomy and overall well-being of the individual.
Importance of Differential Diagnosis and Detailed Medical History
In the specialty of Allergy and Immunology, two patients with seemingly similar symptoms involving What Are the Main Diseases may present completely distinct pathophysiological mechanisms. For this reason, a thorough clinical history—investigating the chronology of flare-ups, home and work environment, family history of atopy, use of concomitant medications, and dietary habits—serves as an indispensable compass for correctly interpreting laboratory tests (such as total and specific IgE levels) and functional tests. A single laboratory result can never replace in-person clinical judgment or specialized telemedicine, preventing misdiagnosis and unnecessary treatments.
Frequently Asked Questions in Clinical Practice
Immunological Reactions to Insect Bites and Prevention of Crises: In allergological practice, distinguishing between local inflammatory edema and a systemic allergic reaction is crucial to protecting the patient's life. In mosquito hypersensitivity, a mixed immune response occurs (immediate mediated by IgE and delayed cellular response by T lymphocytes), causing a single bite to reactivate old lesions throughout the body. In reactions to bees and wasps, symptoms distant from the sting site—such as generalized plaques, hoarseness, bronchospasm, or a drop in blood pressure—characterize anaphylaxis and require immediate intervention.
Mechanisms of Food Allergy, Accurate Diagnosis and Nutritional Management: In contemporary allergology, it is essential to differentiate the immunological reaction against food proteins—such as casein, alpha-lactalbumin, and beta-lactoglobulin in cow's milk, ovomucoid in eggs, or tropomyosin in crustaceans—from non-immune digestive intolerances, such as lactase enzyme deficiency. While intolerance causes abdominal distension, flatulence, and osmotic diarrhea restricted to the digestive tract, food allergy involves Th2 lymphocytes and IgE antibodies or eosinophilic cellular inflammation, and can cause acute urticaria, angioedema, bronchospasm, proctocolitis, or anaphylaxis within minutes of ingesting trace amounts.
Skin Barrier Health, Immune Inflammation, and Pruritus Control: The skin acts as the first organ of immune defense in the human body. In atopic dermatitis, genetic alterations in structural proteins of the stratum corneum (such as filaggrin) and in the composition of ceramides cause transepidermal water loss, pronounced dryness, and facilitated entry of mites and aeroallergens. This microenvironment activates Th2 cytokines (especially IL-4, IL-13, and IL-31, directly linked to intense itching) and favors colonization by Staphylococcus aureus, whose superantigens perpetuate eczematous flare-ups.
Immunology of Cutaneous Autoimmune Diseases and Integrated Care: At the interface between Clinical Immunology, Dermatology, and Rheumatology, a systemic patient assessment allows for the early recognition of metabolic and joint comorbidities, as well as any coexisting hypersensitivities. Tests such as the Antinuclear Antibody (ANA) and inflammatory markers act as screening tools that only acquire real diagnostic significance when interpreted in light of a detailed physical examination of the skin, nails, scalp, and joints.
Pathophysiology of Urticaria and Angioedema: Safe Diagnosis and Management: Urticaria is characterized by the sudden appearance of hives (intensely itchy, erythematous and edematous papules that are fleeting and disappear in less than 24 hours in the same spot without leaving a scar), and may be accompanied by angioedema in the deeper layers of the dermis and submucosa. In acute cases (lasting less than six weeks), viral infections, foods, and medications are among the classic triggers; while in chronic spontaneous urticaria or induced urticaria (dermographic, cholinergic due to sweat/heat, cold, or delayed pressure), autoimmune mechanisms or mast cell hyperreactivity play a central role.
Control of Bronchial Inflammation, Lung Function, and Prevention of Remodeling: Objective monitoring through spirometry (pulmonary function test with bronchodilator test) is indispensable even during periods when the patient believes they are asymptomatic, as it detects silent obstructions in small airways. Modern inhaled corticosteroids act directly on the respiratory mucosa in doses measured in micrograms, offering high systemic safety, reducing severe exacerbations, and protecting respiratory capacity in the long term.
Unified Airway: Management of Rhinitis, Rhinosinusitis, and Nasal Hypersensitivity: The nose performs vital functions of filtering, warming, and humidifying inhaled air before it reaches the lungs. In allergic rhinitis and chronic rhinosinusitis, contact between aeroallergens—especially house dust mites (Dermatophagoides pteronyssinus and Blomia tropicalis), anemophilous fungi, and epithelia—and IgE antibodies fixed to mast cells in the nasal mucosa triggers the immediate release of histamine, leukotrienes, and prostaglandins. This process generates nasal obstruction, itching, sneezing fits, post-nasal drip (a frequent cause of chronic nighttime cough), and vascular fragility that can favor minor bleeding (epistaxis) due to trauma from blowing the nose or from poorly directed sprays.
Pharmacological Safety, Adverse Drug Reactions, and Rational Use of Corticosteroids: Another critical pharmacovigilance point concerns the indiscriminate use of long-acting oral or injectable systemic corticosteroids (such as intramuscular betamethasone combinations). Although they provide apparent rapid relief, repeated applications suppress the hypothalamic-pituitary-adrenal axis, raise blood pressure and blood glucose, demineralize bone mass, weaken immunity against infections, and can cause local neuropathic pain when improperly applied to the gluteal region.
Safe Immunization, Immune Response, and Protection of the Allergic Patient: Preventive immunization represents one of the greatest achievements of medicine in reducing hospitalizations and serious infectious complications, especially in patients with chronic respiratory diseases (such as asthma and COPD), heart disease, high blood pressure, and diabetes. Patients allergic to aeroallergens, foods, or common medications do not have a general contraindication to vaccines; allergological attention focuses on the specific evaluation of rare cases of previous anaphylaxis to isolated components of the formula (such as polyethylene glycol, polysorbate, or specific protein traces), situations that now have safe assisted application protocols.
Precision Medicine: How Monoclonal Antibodies and Immunobiologics Work: Choosing the ideal immunobiological agent requires rigorous phenotyping and endotyping by a specialist physician, evaluating blood biomarkers (peripheral eosinophil count, serum levels of total IgE and exhaled fraction of nitric oxide) and coexisting comorbidities, such as severe asthma, nasal polyposis, refractory chronic spontaneous urticaria, and moderate to severe atopic dermatitis. Subcutaneous applications follow a regular schedule under safe clinical supervision.
Diamond Plan: Specialized Allergy Treatment Wherever You Are
We know that, for many families, allergy treatment faces two concrete obstacles: high cost of allergy vaccines and the distance to a specialized centerThe Diamond Plan It was created precisely to remove these barriers, combining teleconsultation with specialists and easy access to immunotherapy throughout the country. Complex immunological diseases require specialized and continuous monitoring.
Why do patients across Brazil choose the Diamond Plan?
- Teleconsultation with a specialist In Allergy and Immunology, without queues and without long commutes — ideal for those who live far from large cities.
- easy access to Immunotherapy (including allergy vaccines and immunostimulants) — indicated for the treatment of allergic rhinitis, asthma, bronchitis, atopic dermatitis, insect/mosquito bite allergy (prurigo strophulus), recurrent candidiasis, and for increasing immunity in selected patients — capable of modifying the natural course of allergic disease, always through consultation and individualized prescription.
- A more accessible route For those facing the high cost of allergy vaccines, this plan offers support for continuity of treatment.
- Continuous monitoring based on clinical evolution, with adjustments to treatment throughout the entire therapeutic cycle.
- National coverage, backed by a consolidated physical network and a founding clinical team with over three decades of experience.
More than 30 years caring for people with allergies.
Founded and run by Dr. Marcello Bossois (CRM-RJ 52.73214-1) and by Dr. Patrícia Schlinkert (CRM/RJ 5274541-3)The Brazil Without Allergies Project adds... more than 30 years of history and more than 450,000 free services, with physical presence at Rio de Janeiro, São Paulo and Paraná, one mobile clinic bus that brings testing and consultations to communities with limited access to specialized care and a platform of telemedicine which connects patients from all states to the same standard of care.
START TODAY
Your expert consultation is just a click away.
I want to join the Diamond Plan.Schedule a teleconsultation
Official telemedicine environment: brasilsemalergia.online
Do you prefer to be served in person?
Our clinical units They conduct consultations, allergy tests, and immunotherapy follow-up with doctors in person:
- Rio de Janeiro: Realengo (West Zone), North Zone, Duke of Caxias, Xerém, New Iguaçu, Itaguaí, Niterói, Iguaba Grande and Saint Peter of the Village (Lakes Region).
- São Paulo: Campo Limpo (South Zone).
- Paraná: Curitiba.
Schedule your in-person appointment. Or check the mobile bus schedule through the customer service center on WhatsApp. (21) 99954-5632.
The indication for immunotherapy, and for any treatment, depends on an individual medical evaluation. This content is for informational purposes only and does not replace consultation with a specialist.
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Conclusion and Summary of Guidelines
It is concluded that the efficient management of issues related to What are the main diseases? It relies on the combination of high-quality scientific information, environmental prevention, and therapy tailored to each patient's profile. In the face of persistent or recurring symptoms, seek evaluation with an allergist and immunologist—integrating thorough diagnostic investigation and established treatment options. allergy vaccine Whenever indicated — ensures clinical safety and long-lasting health protection.
Scientific references and authoritative sources
The guidelines on this page follow the guidelines and literature of leading international Allergy and Immunology institutions. For further information:




